Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$536,929,681
+$152,432,710 QoQ
Shares Held
447,654
+7.1% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
2.06%
of 13F equity value
Holder Rank
#137
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $2,298,575,113 across 12 Drug Manufacturers - General names. LLY ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,979,150 | $1,513,006,423 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
447,654 | $536,929,681 | |
| 3 | JNJ |
Johnson & Johnson
|
691,961 | $175,737,335 | |
| 4 | MRK |
Merck & Co., Inc.
|
207,542 | $26,669,147 | |
| 5 | ABBV |
AbbVie Inc.
|
65,288 | $16,429,072 | |
| 6 | PFE |
Pfizer Inc
|
433,531 | $10,439,426 | |
| 7 | AMGN |
Amgen Inc
|
20,628 | $7,469,811 | |
| 8 | NVS |
Novartis AG
|
43,692 | $6,847,410 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $536,929,681 | 447,654 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $384,496,971 | 418,036 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $421,440,099 | 392,154 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $259,372,694 | 339,938 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $214,369,970 | 274,999 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $185,151,677 | 224,179 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $146,483,912 | 189,746 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $139,000,442 | 156,896 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $117,119,956 | 129,360 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $75,623,935 | 97,208 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $43,323,780 | 74,322 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $38,792,602 | 72,222 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $26,459,382 | 56,419 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $20,081,141 | 58,474 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,680,775 | 59,263 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,618,089 | 63,764 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,848,089 | 73,553 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $21,643,558 | 75,579 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $21,262,310 | 76,976 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $18,461,588 | 79,903 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $18,921,169 | 82,438 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $15,079,363 | 80,716 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $13,765,018 | 81,527 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,310,823 | 83,170 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $13,476,222 | 82,082 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $11,646,098 | 83,954 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||